As a rate-limiting enzyme of nucleotide metabolism pathway, DHODH seemed to contribute to malignant characteristics of various tumors, including multiple myeloma [16], chronic lymphocytic leukemia [34–37], neuroblastoma [38], colon cancer [9], prostate cancer [39], and so on. The gene discussed is DHODH; the disease is prostate carcinoma.